New Lung Institute in Munich
Lung diseases among the world the most common causes of death, their importance to forecasts of the World Health Organization in the next 20 years will grow even further. Their research but has a large backlog in Germany. Now at the Helmholtz Centre Munich 1 November 2008 a new, pneumologisches Research Institute under the direction of the medical Dr. Oliver Eickelberg established. This is clear from the previous inhalation Institute of Biology. Eickelberg, along with a date to be appointed Pneumologen the clinical management of the Translation Centre for Lung Research (Comprehensive Pneumology Center - CPC). Parallel to this, he receives a call on the newly established Institute of Experimental Lung at the Ludwig-Maximilians University of Munich.
As a partner of the CPC bring the Medical Faculty of the Ludwig-Maximilians University (LMU) in Munich and the Asklepios specialised hospitals for lung diseases in Gauting their experiences in experimental and clinical research, says Prof. Dietrich Reinhardt, dean of the Faculty of Medicine of the LMU. A laboratory complex at the Max-Lebsche place in the immediate vicinity of the Grosshadern clinic will be based on a total area of 1,500 square meters within the meaning translational research working groups of the two chairs of experimental and clinical Pneumology network. For the future we hope this cooperation between research and clinical care important lessons for the benefit of patients, said Dr. Tobias Kaltenbach, Chairman of the Board of Management of Asklepios specialist clinics.
With the establishment of the Institute pneumologischen and the building of the CPC are important steps have been taken to address the situation of lung research being done, says Prof. Dr. Günther Wess, Scientific, Technical Director of the Helmholtz Centre Munich. The region Munich medium can play a leading role in pulmonary medicine in Germany - if not in Europe -. In addition expands the Helmholtz Centre Munich with the new institute focusing on specific disease Image. The scientific focus of research at the CPC are bronchial asthma, COPD, interstitial Pneumopathien, lung cancer, lung transplantation, and aspects of stem cell research. We will CPC on the molecular mechanisms of these lung diseases explore new therapeutic approaches for their treatment and develop as quickly as possible for the benefit of patients in clinical trials to test Eickelberg explains.
Comments
One Response to “New Lung Institute in Munich”
Leave a Reply
[…] Original admin […]